贝伐和特罗凯---楼主你历害,这样都找到了,我在网上看了,这个组合不比PD1差
63% of patients remained free of cancer progression for at least 16 weeks.
63%可以得到16周的肿瘤无进展期
Median overall survival was 15.6 months.
中位生存期15.6月
Serious adverse effects of treatment included fatigue, hypertension, diarrhea, elevated liver enzymes, and gastrointestinal bleeding.
注意不利的作用是疲劳,高血压,腹泻,各种酶高,胃出血
|